Safety and Efficacy of Product 33525 (Luliconazole Cream 1%) in Pediatric Participants With Tinea Corporis
Status:
Completed
Trial end date:
2016-09-22
Target enrollment:
Participant gender:
Summary
The objective of this study was to evaluate the safety, efficacy, and pharmacokinetics of
luliconazole cream 1% when applied topically for 7 days in pediatric participants 2 years to
17 years of age (inclusive) with tinea corporis.
Phase:
Phase 4
Details
Lead Sponsor:
Bausch Health Americas, Inc. Valeant Pharmaceuticals